The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
NanoViricides, Inc(NYSE MKT:NNVC) 
NanoViricides, Inc., a nano-biopharmaceutical company, discovers, develops, and commercializes drugs for the treatment of viral infections. Its products pipeline includes HerpeCide Dermal Topical and Eye Drops for the treatment of shingles, PHN, chickenpox, herpes, recurrent herpes labialis, genital...
Website: http://www.nanoviricides.com
Founded: 2005
Full Time Employees: 17
Sector: Healthcare
Industry: Biotechnology
NanoViricides Number of Twitter Followers
NanoViricides Days Payable Outstanding ttm (DPO)
NanoViricides Op Cashflow Per Share ttm
NanoViricides Free Cashflow Per Share ttm
NanoViricides Cash Per Share ttm
NanoViricides (GAAP) P/E ratio ttm
NanoViricides P/B ratio ttm
No extra charts and metrics for this ticker.